CAMPTOSAR vs REVUFORJ

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. CAMPTOSAR and REVUFORJ are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	CAMPTOSAR	REVUFORJ
Rating	64/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	IRINOTECAN HYDROCHLORIDE	REVUMENIB CITRATE
Manufacturer	Pfizer	Syndax
Dosage forms	Injectable	Tablet
Drug class	Topoisomerase Inhibitor	Menin Inhibitor
Boxed warning	Boxed warning	Boxed warning
Treats	Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Colonic Neoplasms	Leukemia

camptosar revuforj

Rating

64/100

New

Pharmacy pays

—

Type

Active ingredient

IRINOTECAN HYDROCHLORIDE

REVUMENIB CITRATE

Manufacturer

Pfizer

Syndax

Dosage forms

Injectable

Tablet

Drug class

Topoisomerase Inhibitor

Menin Inhibitor

Boxed warning

Treats

Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Colonic Neoplasms

Leukemia

Frequently asked questions

What is the difference between Camptosar and Revuforj?

Camptosar contains Irinotecan Hydrochloride, while Revuforj contains Revumenib Citrate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.